Filters
reset allResults: 1 to 12 of 12
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Macular Dystrophy Panel Invitae United States | 66 | 36 |
|
Invitae Corneal Dystrophies Panel Invitae United States | 65 | 33 |
|
Invitae Supplemental Metabolic Newborn Screening Panel Invitae United States | 253 | 189 |
|
Anterior Segment Dysgenesis Disorders Panel PreventionGenetics, part of Exact Sciences United States | 272 | 278 |
|
Invitae Congenital Disorders of Glycosylation Panel Invitae United States | 203 | 152 |
|
PreventionGenetics, part of Exact Sciences United States | 40 | 27 |
|
Macular Corneal Dystrophy (MCD) via the CHST6 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Integrated Genetics Westborough LabCorp United States | 287 | 578 |
|
Fulgent Genetics United States | 47 | 24 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Comprehensive Eye Disorders NGS Panel Fulgent Genetics United States | 1018 | 459 |
|
Results: 1 to 12 of 12
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.